A total of 204 patients with maxillofacial cavernous haemangiomas were examined by digital subtraction angiography to investigate the factors affecting therapeutic outcome and to optimize treatment selection. Cavernous haemangiomas were classified as high-or low-drainage based on the nature of the draining veins. Patients were randomized to receive either embolization of the draining veins with absolute ethanol followed by bleomycin A5 hydrochloride intra-tumoural injection, or intratumoural injection only. In patients with high-drainage haemangiomas (n = 140), there were significant improvements in the complete cure rate and the overall effective rate in those who had received embolization prior to intra-tumoural injection compared with those who had received intra-tumoural injection only. In patients with low-drainage haemangiomas (n = 64), there were no significant differences between the two treatment groups. It is concluded that embolotherapy of draining veins prior to hydrochloride injection is effective for treating high-drainage cavernous haemangiomas whereas bleomycin A5 hydrochloride injection alone is suitable for treating low-drainage cavernous haemangiomas.
Introduction
Cavernous haemangioma, also known as venous malformation, is a frequently encountered benign tumour of the head and facial region. 1 Previous studies have reported various treatment protocols, laying emphasis on the methods and results rather than the rationale behind the poor therapeutic outcome. 1 -15 In the present study, digital subtraction angiography (DSA) was used to classify the maxillofacial cavernous haemangiomas of 204 patients into two discrete groups (high-drainage or lowdrainage). Patients were then randomized to receive either ethanol embolization and bleomycin A5 hydrochloride intra-tumoural injection or the latter treatment alone. Factors affecting therapeutic outcome and the optimization of treatment selection were explored.
Patients and methods PATIENTS
Patients with maxillofacial cavernous haemangioma, who had visited the Special Department of Haemangioma of Linyi Tumour Hospital in Shandong Province, China since 1995, were included in the study. Allergy tests of the contrast agent, ethanol and bleomycin A5 hydrochloride were routinely performed before undertaking DSA and treatment procedures. Patients who tested positive were excluded from the study.
The protocol of the study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of Linyi Tumour Hospital. Each patient signed an agreement of participation in the study that had been approved by Linyi Tumour Hospital.
DSA IMAGING PROCEDURE
A 7 -9 gauge Blaun interventional puncture needle (Zibo Blaun Puncture Technical Inc., Shandong, China) was selected, depending on the size of the lesion, and was used to puncture percutaneously into the haemangioma cavity at a site defined using a pre-contrast DSA image. The position of the needle was adjusted until a good blood return (i.e. blood spurt from the tail of the needle) was achieved, indicating desired intravenous positioning. Subsequently, 30 -100 ml of 30% meglucamine diatrizoate contrast agent (Angiografin; Schering Pharmaceuticals Ltd, Guangzhou, China) was administered with a high pressure injector, the precise volume used being tailored according to lesion size. Immediately, DSA imaging was initiated at a rate of 3 -6 frames/s and continued for 3 -10 s, depending on the size of the lesion. Single puncture site DSA imaging was used to classify lesions, according to the criteria detailed below, and to observe lesion size and location.
DRAINAGE CLASSIFICATION
The haemangiomas were classified into two types, high-drainage and low-drainage, according to the thickness, quantity and flow velocity of the draining veins. The classification of low-drainage fulfilled the following criteria: fine draining veins with diameter < 0.3 cm; commonly one or two draining veins; low draining velocity; and obvious contrast agent residue in the haemangioma 5 min after DSA. Criteria for high-drainage were: large draining veins with a diameter between 0.4 and 0.7 cm; commonly more than two draining veins; high draining velocity; and only a small amount of contrast agent residue found in the haemangioma 5 min after angiography.
TREATMENT
Patients classified as having high-or lowdrainage types of haemangioma were randomized to receive either embolization of the draining veins prior to injection with bleomycin A5 hydrochloride (Tianjin Taihe Pharmaceutical Co. Ltd., Tianjin, China) or bleomycin A5 hydrochloride injection only. The bleomycin A5 hydrochloride doses were diluted with 3 ml sterile water prior to injection into the vascular pool of the haemangioma. Children who could not tolerate the pain of the treatment were anaesthetised with 2 mg/kg ketamine.
Embolization of draining veins prior to bleomycin A5 hydrochloride injection
For embolization of the draining veins prior to injection with bleomycin A5 hydrochloride, the position of the angiographic puncture needle was maintained while absolute ethanol was injected into the cavity at a speed and dose dependent on the drainage classification of the haemangioma (Table 1 ). After half the Classification and therapy of maxillofacial cavernous haemangioma dose had been injected a 1 -2 min pause was observed to monitor the reaction of the patient and to ensure no complications had arisen, before proceeding to complete the dose. Simultaneous mechanical compression of the venous outlets was performed while injecting so as to decrease the number of open draining veins. The position of the angiographic puncture needle was maintained to enable the DSA imaging procedure to be repeated 10 -15 min following ethanol embolization to determine the level of success. If most draining veins were found to be embolized, 8 mg bleomycin A5 hydrochloride was injected into the vascular pool of the haemangioma. Injection of absolute ethanol was then repeated at the same site (again with mechanical compression applied), to a maximum cumulative dose of 6 ml if the desired embolization was not achieved. The DSA imaging procedure was repeated for a second time to determine the success of embolization after giving the maximum dosage of absolute ethanol.
For small (3 -5 cm diameter) and medium (6 -10 cm diameter) sized haemangiomas, embolization at a single percutaneous injection site was often sufficient. Large (> 10 cm diameter) haemangiomas, however, required repeat embolization at different injection sites every 3 -5 days for up to 20 days. The concomitant DSA imaging and embolization procedures could be repeated at three to four sites in one treatment session.
Bleomycin A5 hydrochloride injection without prior embolization
Bleomycin A5 hydrochloride (8 -16 mg) was injected into the vascular pool of the lesion. The procedure was repeated at an interval of 5 -7 days for a maximum of 35 days, with 3 -5 doses administered at the same puncture site in one treatment session.
PATIENT OUTCOME CRITERIA
The criteria for categorization of patient outcome were: 16, 17 (i) completely curedlesions disappeared completely, good appearance, Valsalva's test negative and no recurrence at follow-up at least half a year post-treatment; (ii) improved -50% shrinkage of lesions, lessened malformation, negativeor positive-postural test and prolonged time before recurrence; and (iii) no effect -no change or an increased size of lesions.
STATISTICAL ANALYSIS
The results were analysed by SPSS ® version 10.0 software (SPSS Inc., Chicago, IL, USA) using the χ 2 -test to compare the two treatment groups. Data showing a P-value < 0.05 were considered to be statistically significant.
Haemangioma diameter

Small (3 -5 cm)
Medium (6 -10 cm) Large (> 10 cm) While most haemangiomas were within the range 6 -10 cm in diameter, 72 patients had haemangiomas > 10 cm in diameter. Table 2 shows the relationship between haemangiomas classified as high-or lowdrainage and their size in terms of numbers of patients. The submaxillary region and parotideomasseteric region were the most frequently infiltrated sites. All 204 patients were followed-up for 0.5 -5 years.
EFFICACY OUTCOMES
There were significant improvements in patients with high-drainage haemangiomas who had received embolization prior to bleomycin A5 hydrochloride injection compared with those who received bleomycin A5 hydrochloride injection only in terms of completely cured haemangiomas and the overall effective rate (χ 2 = 2.26; P < 0.01; Table 3 ). In patients with low-drainage haemangiomas, there were no significant differences between patients who underwent absolute ethanol embolization of the draining veins followed by bleomycin A5 hydrochloride intra-tumoural injection and those who received bleomycin A5 hydrochloride injection treatment only ( Table 4 ). Comparison of patients with lowversus high-drainage haemangiomas (i.e. comparison regardless of treatment), showed significant differences in terms of completely cured haemangiomas and overall effective 
SAFETY OUTCOMES
Of the 110 patients who underwent ethanol venous embolization, obvious swelling of lesion sites presented in all patients and lesion pain occurred in 31 (28.2%) patients, although this was relieved by oral analgesics ( 
TABLE 4: Comparison of treatment effects in 64 patients classified with low-drainage cavernous haemangioma who received either absolute ethanol embolization of the draining veins followed by bleomycin (BLM) A5 hydrochloride intra-tumoural injection or bleomycin A5 hydrochloride intra-tumoural injection only
Comparison of safety outcomes in patients with cavernous haemangioma who received either absolute ethanol embolization of the draining veins followed by bleomycin (BLM) A5 hydrochloride intra-tumoural injection or bleomycin A5 hydrochloride intra-tumoural injection only
X-J Liu, Z-P Qin, M-Z Tai Classification and therapy of maxillofacial cavernous haemangioma 39.0°C) occurred in 14 (12.7%) patients, all of whom recovered within 2 days. Transient facial palsy occurred in 12 (10.9%) patients with low-drainage veins, which resolved spontaneously after subsidence of the swelling. Of the 94 patients treated with bleomycin A5 hydrochloride injection alone, a high fever (temperature > 39°C) was observed in nine (9.6%) patients and slight fever in eight (8.5%). All cases of fever resolved after symptomatic treatment and there were no notable differences in safety outcomes between the low-and highdrainage patient groups.
Discussion
An improved therapeutic effect was achieved by treating cavernous haemangiomas according to classification based on the thickness, quantity and flow velocity of the draining veins (i.e. low-versus highdrainage veins). Classification of the draining veins of the haemangiomas was found to be a crucial predictor of therapeutic effect in the treatment of patients with maxillofacial cavernous haemangioma. Embolotherapy of draining veins prior to bleomycin A5 hydrochloride injection appeared an effective treatment for highdrainage cavernous haemangioma, whereas bleomycin A5 hydrochloride injection alone was suitable for treating low-drainage cavernous haemangioma.
Previous clinical treatment of cavernous haemangioma has highlighted the unsatisfactory effect of sclerosing agents in treating large lesions, with fewer easily cured cases than in other lesion sizes. 18 On the contrary, for medium and small sized lesions, the effect of repeated injection of sclerosing agents was non-significant. 18 Puncture of facial cavernous haemangioma was routinely conducted in the present study, and subsequent DSA imaging enabled observation of notable differences among the draining veins in the lesions. The effects of sclerotherapy also varied greatly. Through observation and analysis, the cavernous haemangiomas were classified into two types: high-drainage and low-drainage, according to the thickness and quantity of the draining veins and the flow velocity, in order to optimize treatment selection and enable improved prognosis prediction. In high-drainage cavernous haemangiomas, a 14.3% overall effective rate implied that treatment with bleomycin A5 hydrochloride alone was inadequate. For patients of the same classification, when absolute ethanol embolizations were administered before the injection of bleomycin A5 hydrochloride, the effective rate was increased to 100.0%.
Absolute ethanol, as an embolizing agent, exerts its effect through inducing strong vessel constriction and results in damage to the endothelium of the draining veins, subsequently causing rapid thrombosis of the blood within the venous malformation. This function is compromised once it flows into larger veins due to dilution. 18, 19 None of the 110 patients receiving ethanol sclerotherapy in the present study showed any degree of large vein embolism or pulmonary embolism. The quantity and speed of the absolute ethanol injection must be appropriate, however, because too small a dose or too slow a flow results in an inadequate effect whereas too great a dose or too fast a flow may cause unpredictable complications. 20 Mechanical forms subsequently. If the above procedures can effectively embolize the draining veins one by one, it prolongs the time bleomycin A5 hydrochloride is in contact with the vessel lining, resulting in continuous damage to the endothelial cells and leading to the desired therapeutic effect. 18 Of the 110 patients who received draining venous embolotherapy in the present study, apart from 10 patients who had giant unilateral facial haemangioma that were obviously shrunken and still under treatment, 100 patients were completely cured. The complete cure rate was, therefore, 90.9%, whereas the overall effective rate was 100.0%.
To be suitable for venous embolization therapy, the vessels and the haemangioma cavities being treated must be large and spacious enough to allow embolization. Thus, the high-drainage cavernous haemangioma classification signifies that embolotherapy is both appropriate and beneficial to the patient.
For low-drainage cavernous haemangioma, the present study showed that bleomycin A5 hydrochloride, alone could achieve an 84.2% complete cure rate and a 100.0% effective rate. For this classification of cavernous haemangioma, ethanol venous embolization would exacerbate patient suffering by causing severe swelling, aggravated pain and, in rare cases, transient facial palsy or necrosis of skin local to the haemangioma. Thus, for low-drainage haemangiomas, intratumoural injection of bleomycin A5 hydrochloride alone should be the first choice of treatment.
